GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Change In Payables And Accrued Expense

AKAN (Akanda) Change In Payables And Accrued Expense : $-0.78 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Akanda Change In Payables And Accrued Expense?

Akanda's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was $-0.29 Mil. It means Akanda's Accounts Payable & Accrued Expense declined by $0.29 Mil from Jun. 2024 to Dec. 2024 .

Akanda's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $-0.78 Mil. It means Akanda's Accounts Payable & Accrued Expense declined by $0.78 Mil from Dec. 2023 to Dec. 2024 .

Akanda Change In Payables And Accrued Expense Historical Data

The historical data trend for Akanda's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Change In Payables And Accrued Expense Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial 0.14 - 2.98 1.63 -0.78

Akanda Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only 2.53 1.03 0.60 -0.49 -0.29

Akanda Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akanda Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Akanda's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
UPC CANN CPMD INM OWPC CANB MSTH FLHLF PRFX SHPH ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
Y230:Germany
Address
c/o Gowling WLG, 100 King Street W, Suite 1600, Toronto, ON, CAN, M5X 1G5
Website
https://www.akandacorp.com
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.